9AA FDA Approved (obstetric) / Phase II–III (psychiatric)
Oxytocin
The original 'bonding hormone' — FDA-approved for labour induction and widely studied for autism, PTSD, and social anxiety.
In Plain English: A nine-amino-acid peptide your hypothalamus makes naturally and releases during childbirth, breastfeeding, sex, and close social contact. Synthetic oxytocin (Pitocin) has been FDA-approved since the 1960s for obstetric use. Researchers are now testing intranasal oxytocin as a psychiatric adjunct — sprayed into the nose, it reaches the brain via olfactory nerves and temporarily sharpens social recognition, reduces amygdala fear reactivity, and may improve therapy outcomes for autism and PTSD.
Research Maturity
FDA Approved (obstetric) / Phase II–III (psychiatric) (33,480 publications indexed on PubMed (searched 2026-05-04); >2,000 human clinical studies+ Studies)
Quick Facts
Focus
Lactation Support
Neuroendocrine & Social Signaling
Obstetrics & Labor
Route
IM
Intranasal
IV
Origin
Endogenous nonapeptide; produced in the paraventricular and supraoptic nuclei of the hypothalamus, released from the posterior pituitary. Synthetic form (Pitocin/Syntocinon) produced by solid-phase peptide synthesis.
Mechanism
Binds G-protein-coupled oxytocin receptors (OXTR) in uterine myometrium, breast myoepithelial cells, and CNS limbic structures. Peripheral: raises intracellular Ca²⁺, triggering uterine contractions and milk ejection via positive feedback. Central (intranasal route): delivered trans-nasally via CN-I/CN-V pathways, acts on amygdala, hypothalamus, and nucleus accumbens to enhance social salience, dampen threat appraisal, promote trust, and modulate HPA-axis cortisol release.
Outcome
Obstetric: labour induction and postpartum haemorrhage control (A-grade evidence). CNS: reduced social anxiety and improved facial-emotion recognition in RCTs; mixed results for autism core symptoms; preliminary PTSD fear-extinction facilitation.
Safety Flags & Warnings
FDA Approved (Pitocin)
Context-Dependent CNS Effects
Antidiuretic Risk at High Dose
Obstetric Contraindications (IV)
Purity Variability (Research Grade)
Always consult a licensed physician. Research purposes only.
€4.5 / mg
